CLINICAL_TRIALS
trial_result
· 2011-10-07
Clinical Trial Update: Ologen (OculusGen)-Glaucoma MMC Control in Pakistan [Phase 3]
Summary
Phase 3 clinical trial evaluating Ologen (OculusGen) for glaucoma surgery with MMC control has completed in Pakistan.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pro Top & Mediking Company Limited | Conditions: Glaucoma, Trabeculectomy | Phase 3 | Status: COMPLETED